Abstract
We conducted in vitro studies and a clinical trial for patients with squamous cell carcinoma of the head and neck (SCCHN) to study the relationship between FcγRIIIa polymorphisms and antibody-dependent cellular cytotoxicity (ADCC). In vitro, FcγRIIIa genotype was correlated with ADCC and innate cytotoxicity using natural killer (NK) cells harvested from healthy donors. In the phase II study, patients with recurrent or metastatic SCCHN were treated with cetuximab (500 mg/m(2) i.v. every 2 weeks) and lenalidomide (25 mg daily). FcγRIIIa genotype and ex vivo ADCC were correlated with clinical response, progression-free survival (PFS), and overall survival (OS). In vitro, healthy donors with a FcγRIIIa 158-V allele demonstrated more effective ADCC against two colon cancer cell lines HT29 and SW480, mean cytotoxicity: FF 16.1%, VF/VV 24.3% (P = 0.015) and FF 11.7%, VF/VV 21.0% (P = 0.008), respectively. We observed a linear relationship between ADCC response and innate cytotoxicity. In the phase II trial, 40 patients received cetuximab and lenalidomide with median PFS of 7.2 weeks and OS of 16.4 weeks. Thirty-six patients had FcγRIIIa genotype: VV (2), VF (20), and FF (14), and 25 patients had sufficient NK-cell yield to perform ex ...Continue Reading
References
Jan 25, 2002·Blood·Guillaume CartronHervé Watier
Sep 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wen-Kai Weng, Ronald Levy
Oct 18, 2003·Blood·Sherif S FaragJohn C Byrd
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wen-Kai WengRonald Levy
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven P TreonEdward A Fox
Dec 21, 2005·Journal of Immunotherapy·Béatrice ClémenceauHenri Vié
Jan 13, 2006·British Journal of Cancer·L ArnouldB Coudert
Jan 13, 2006·Cancer Metastasis Reviews·Alexandre Iannello, Ali Ahmad
Jul 26, 2007·Haematologica·Emanuela CarlottiAlessandro Rambaldi
Aug 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wu ZhangHeinz-Josef Lenz
Oct 5, 2007·The Oncologist·Scott E StromeDean Mann
Jun 4, 2008·Blood·Wei LinScott E Strome
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lei WuJ Blake Bartlett
Nov 4, 2008·Cancer Immunology, Immunotherapy : CII·Rodney J TaylorScott E Strome
Dec 20, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jan BogaertsUNKNOWN RECIST Working Party
Jan 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven P TreonKenneth C Anderson
Jan 24, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frédéric BibeauFlorence Boissière-Michot
Jul 1, 2009·American Journal of Hematology·Liang ZhangMichael Wang
Mar 31, 2010·Seminars in Hematology·George J Weiner
Sep 18, 2010·Cancer Immunology, Immunotherapy : CII·Lei WuJ Blake Bartlett
Jul 27, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jan PanderThorbald van Hall
Mar 13, 2014·British Journal of Haematology·Joseph M TuscanoRobert T O'Donnell
Oct 15, 2014·BioMed Research International·Andrea Acebes-HuertaSegundo Gonzalez
Citations
Dec 19, 2015·Cancer Cell·Lorenzo GalluzziGuido Kroemer
Nov 17, 2015·Hematology/oncology Clinics of North America·David W Schoppy, John B Sunwoo
Jul 26, 2018·Oncotarget·Claudius MelzigAmir Abdollahi
Jun 17, 2020·British Journal of Cancer·Hasan BaysalAn Wouters
Jul 19, 2017·The Pharmacogenomics Journal·T MagnesA Egle
May 4, 2018·Oncoimmunology·O AdoteviC Borg
Feb 7, 2019·Frontiers in Oncology·Susmita GhoshAngel Porgador
May 31, 2019·Frontiers in Immunology·Daniel E GeraghtyRasmi Thomas
Mar 11, 2020·Frontiers in Immunology·Aviad Ben-ShmuelMira Barda-Saad
Feb 16, 2017·Cancer Immunology, Immunotherapy : CII·Laura LattanzioMarco Merlano
Aug 10, 2018·Targeted Oncology·Lorenzo MortaraLeonardo Campiotti
May 26, 2017·Frontiers in Oncology·Athanassios ArgirisLisa Licitra
May 12, 2018·Scientific Reports·Sofia RomanoJoão Gonçalves
Jan 29, 2016·Cancer Immunology Research·Anna Maria TrottaStefania Scala
May 2, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laura K van DijkJohan Bussink
Nov 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amy K ErbePaul M Sondel
Feb 20, 2021·Critical Reviews in Oncology/hematology·Mélanie GauthierVéronique Decot
Jun 24, 2018·Antibody Therapeutics·David ZahaviLouis M Weiner
May 3, 2021·Journal of Translational Medicine·Shiqi LongXing Zhao
May 15, 2021·The Lancet Oncology·Assuntina G SaccoEzra E W Cohen